Your browser doesn't support javascript.
loading
Mutant p53 as an Antigen in Cancer Immunotherapy.
Sobhani, Navid; D'Angelo, Alberto; Wang, Xu; Young, Ken H; Generali, Daniele; Li, Yong.
Afiliação
  • Sobhani N; Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • D'Angelo A; Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.
  • Wang X; Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Young KH; Department of Pathology, Duke University School of Medicine, Durham, NC 27708, USA.
  • Generali D; Department of Medical, Surgical and Health Sciences, University of Trieste, Cattinara Hospital, Strada Di Fiume 447, 34149 Trieste, Italy.
  • Li Y; Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Int J Mol Sci ; 21(11)2020 Jun 08.
Article em En | MEDLINE | ID: mdl-32521648

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Mutação / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Mutação / Antígenos de Neoplasias / Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article